Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group. [electronic resource]
Producer: 20190712Description: 662-670 p. digitalISSN:- 1826-6983
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- DNA Mutational Analysis
- ErbB Receptors -- genetics
- Female
- Humans
- Italy
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- therapeutic use
- Retrospective Studies
- Societies, Medical
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.